Business
Britain’s GSK exits Innoviva stake in $392 million deal
Published by Wanda Rich
Posted on May 20, 2021
· Last updated: January 21, 2026
Related Articles
The Optionality Trap—Why Too Much Flexibility Is Slowing Business Decisions
Why More Choices Are Slowing Businesses Down
Why More Output Isn’t Translating Into Better Results
The Reversibility Problem—Why Businesses Hesitate Even When They Know the Answer
The Alignment Illusion—Why Companies Agree on Strategy but Fail in Execution
More from Business
Explore more articles in the Business category
Attention Is the New Competitive Advantage
The Quiet Strategy Separating Winning Businesses From the Rest
The One Habit That Separates Growing Businesses from the Rest
The Overlooked Edge That Matters More Than Strategy
The Hidden Pattern Behind Business Success
The Power of Pricing: How Smart Pricing Strategies Drive Profitability and Growth
Why Customer Experience Now Defines Success
The New Cost Playbook: Why Strategic Spending Matters More Than Cutting Costs
The Trust Economy: Why Credibility and Transparency Are Driving Business Success
The Hidden Profit Engine: Why Operational Efficiency Is Redefining Business Performance
Built to Withstand: Why Resilience Is Now the Foundation of Sustainable Business Growth
The Agility Imperative: How Fast-Moving Businesses Are Outpacing the Competition